Samsung Electronics, Harvard Medical School Affiliate MGH to Study GLP-1 Treatment Effects Using Galaxy Watch

MT Newswires Live

May 28

Samsung Electronics (KRX:005930) and Harvard Medical School affiliate Massachusetts General Hospital (MGH) will jointly track and analyze physical changes in patients taking glucagon-like peptide-1 (GLP-1) class treatments with the help of the Galaxy Watch.

GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, Samsung Electronics said in a Thursday release.

The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.

Shares of Samsung Electronics fell over 2% at market close.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2638566736"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2638566736\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2638566736?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 18:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2638566736","market":"sh","top_or_hot":-1,"title":"Samsung Electronics, Harvard Medical School Affiliate MGH to Study GLP-1 Treatment Effects Using Galaxy Watch","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SSNGY\">Samsung Electronics</a> (KRX:005930) and Harvard Medical School affiliate Massachusetts General Hospital (MGH) will jointly track and analyze physical changes in patients taking glucagon-like peptide-1 (GLP-1) class treatments with the help of the Galaxy Watch.</p><p>GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, <a href=\"https://laohu8.com/S/SSNHZ\">Samsung Electronics</a> said in a Thursday release.</p><p>The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.</p><p>Shares of <a href=\"https://laohu8.com/S/SSNLF\">Samsung Electronics</a> fell over 2% at market close.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Samsung Electronics, Harvard Medical School Affiliate MGH to Study GLP-1 Treatment Effects Using Galaxy Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSamsung Electronics, Harvard Medical School Affiliate MGH to Study GLP-1 Treatment Effects Using Galaxy Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-28 18:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SSNGY\">Samsung Electronics</a> (KRX:005930) and Harvard Medical School affiliate Massachusetts General Hospital (MGH) will jointly track and analyze physical changes in patients taking glucagon-like peptide-1 (GLP-1) class treatments with the help of the Galaxy Watch.</p><p>GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, <a href=\"https://laohu8.com/S/SSNHZ\">Samsung Electronics</a> said in a Thursday release.</p><p>The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.</p><p>Shares of <a href=\"https://laohu8.com/S/SSNLF\">Samsung Electronics</a> fell over 2% at market close.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EEMO","symbol_name":"Invesco S&P Emerging Markets Momentum ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2638566736","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638566736","pubTimestamp":1779965591,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Samsung Electronics  and Harvard Medical School affiliate Massachusetts General Hospital  will jointly track and analyze physical changes in patients taking glucagon-like peptide-1  class treatments with the help of the Galaxy Watch.GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, Samsung Electronics said in a Thursday release.The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.Shares of Samsung Electronics fell over 2% at market close.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EEMO":"Invesco S&P Emerging Markets Momentum ETF","MGH.AU":"MAAS GROUP HOLDINGS LTD","IEMG":"iShares Core MSCI Emerging Markets ETF","BK4588":"碎股","GLP":"Global Partners Lp","BK4550":"红杉资本持仓","DRAM":"Roundhill Memory ETF","BK4585":"ETF&股票定投概念","BK4590":"PTP","BK7055":"建筑与工程","BK4581":"高盛持仓","WTAI":"WisdomTree Artificial Intelligence and Innovation Fund","EMXC":"iShares MSCI Emerging Markets ex China ETF","BK4144":"石油与天然气的储存和运输","BK4504":"桥水持仓"},"translate_title":"三星电子与哈佛医学院附属MGH将利用Galaxy Watch研究GLP-1治疗效果","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLP":1.5,"MGH.AU":1,"IEMG":1.5,"WTAI":1.5,"EMXC":1.5,"EEMO":1.5,"DRAM":1.5},"content_text":"Samsung Electronics (KRX:005930) and Harvard Medical School affiliate Massachusetts General Hospital (MGH) will jointly track and analyze physical changes in patients taking glucagon-like peptide-1 (GLP-1) class treatments with the help of the Galaxy Watch.GLP-1 is an intestinal hormone that helps regulate blood sugar and suppress appetite, Samsung Electronics said in a Thursday release.The study will assess whether data from the Galaxy Watch 8 and Samsung Health can help manage muscle loss in patients who take GLP-1 drugs by tracking body composition, activity, and heart rate, according to the release.Shares of Samsung Electronics fell over 2% at market close.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}